美国儿童多系统炎症综合征的地理与时间分布趋势
这项横断面分析纳入2020年3月至2021年1月发病的1733例MIS-C患者,发现全国范围内前两个MIS-C高峰均滞后于COVID-19高峰2至5周,累计发病率每10万21岁以下人群为2.1,各州间从0.2至6.3不等。临床表现随年龄及有无前驱COVID-19而不同,1.4%患者死亡。
要点
- MIS-C高峰滞后COVID-19高峰2至5周,提示为延迟免疫反应。
- 累计发病率每10万21岁以下人群2.1,各州间0.2至6.3不等。
- 0至4岁患者重症比例最低,但仍有38.4%低血压或休克。
核心结论
- MIS-C的地理与时间分布与COVID-19大流行相关,提示MIS-C源于对SARS-CoV-2感染的延迟免疫反应。
研究设计与样本
- 横断面分析纳入2020年3月至2021年1月发病且符合MIS-C病例定义的患者,共1733例。
主要发现
- 994例(57.6%)为男性,1117例(71.3%)为西班牙裔或非西班牙裔黑人。
- 胃肠道症状、皮疹和结膜充血报告率为53%(n=931)至67%(n=1153)。
- 937例(54%)有低血压或休克,1009例(58.2%)入住重症监护室。
- 心脏功能障碍484例(31.0%),心包积液365例(23.4%),心肌炎300例(17.3%),冠状动脉扩张或动脉瘤258例(16.5%)。
- 0至4岁患者重症比例最低,但171例(38.4%)有低血压或休克,197例(44.3%)入住重症监护室。
关键数值与推荐
- 全国累计MIS-C发病率每10万21岁以下人群为2.1,各州间从0.2至6.3不等。
- 全国前两个MIS-C高峰滞后COVID-19高峰2至5周。
- 18至20岁患者心肌炎比例最高(17例,30.9%),肺炎20例(36.4%),急性呼吸窘迫综合征10例(18.2%),PCR阳性39例(70.9%)。
- 18至20岁患者报告前驱COVID-19样疾病比例最高(63%)。
临床怎么用
- 临床应警惕MIS-C在COVID-19高峰后2至5周出现,并关注0至4岁患者仍可发生低血压或休克。
- 对18至20岁患者需注意心肌炎、肺炎及急性呼吸窘迫综合征风险较高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Multiple inflammatory syndrome in children (MIS-C) occurs in association with the COVID-19 pandemic. OBJECTIVE: To describe the clinical characteristics and geographic and temporal distribution of the largest cohort of patients with MIS-C in the United States to date. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional analysis was conducted on clinical and laboratory data collected from patients with MIS-C. The analysis included patients with illness onset from March 2020 to January 2021 and met MIS-C case definition. MAIN OUTCOMES AND MEASURES: Geographic and temporal distribution of MIS-C was compared with that of COVID-19 nationally, by region, and level of urbanicity by county. Clinical and laboratory findings and changes over time were described by age group and by presence or absence of preceding COVID-19. RESULTS: A total of 1733 patients with MIS-C were identified; 994 (57.6%) were male and 1117 (71.3%) were Hispanic or non-Hispanic Black. Gastrointestinal symptoms, rash, and conjunctival hyperemia were reported by 53% (n = 931) to 67% (n = 1153) of patients. A total of 937 patients (54%) had hypotension or shock, and 1009 (58.2%) were admitted for intensive care. Cardiac dysfunction was reported in 484 patients (31.0%), pericardial effusion in 365 (23.4%), myocarditis in 300 (17.3%), and coronary artery dilatation or aneurysms in 258 (16.5%). Patients aged 0 to 4 years had the lowest proportion of severe manifestations, although 171 patients (38.4%) had hypotension or shock and 197 (44.3%) were admitted for intensive care. Patients aged 18 to 20 years had the highest proportions with myocarditis (17 [30.9%]), pneumonia (20 [36.4%]), acute respiratory distress syndrome (10 [18.2%]), and polymerase chain reaction positivity (39 [70.9%]). These older adolescents also had the highest proportion reporting preceding COVID-19-like illness (63%). Nationally, the first 2 MIS-C peaks followed the COVID-19 peaks by 2 to 5 weeks. The cumulative MIS-C incidence per 100 000 persons younger than 21 years was 2.1 and varied from 0.2 to 6.3 by state. Twenty-four patients (1.4%) died. CONCLUSIONS AND RELEVANCE: In this cross-sectional study of a large cohort of patients with MIS-C, 2 peaks that followed COVID-19 peaks by 2 to 5 weeks were identified. The geographic and temporal association of MIS-C with the COVID-19 pandemic suggested that MIS-C resulted from delayed immunologic responses to SARS-CoV-2 infection. The clinical manifestations varied by age and by presence or absence of preceding COVID-19.
引用
- Belay ED, Abrams J, Oster ME, et al. Trends in Geographic and Temporal Distribution of US Children With Multisystem Inflammatory Syndrome During the COVID-19 Pandemic. JAMA Pediatr. 2021. PMID: 33821923. doi:10.1001/jamapediatrics.2021.0630
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。